Fellow of Korean Academy of Science and Technology (KAST)

Secretary General of Korean Society of Pharmaceutical Sciences and Technology (KSPST)

Professor, School of Pharmacy, Sungkyunkwan University (SKKU) and Biomedical Institute for Convergence at SKKU (BICS)

Sungkyunkwan University (SKKU), 16419 Suwon, South Korea

Email: ysyoun@skku.edu

Yu Seok Youn is a professor at the School of Pharmacy in Sungkyunkwan University. He earned his Ph.D. degree in 2004, from the School of Pharmacy at Sungkyunkwan University. Following this, he conducted postdoctoral research at Prof. You Han Bae’s lab and the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah (2006-2007). He joined the School of Pharmacy at Sungkyunkwan University in 2011, after serving as an assistant professor at the College of Pharmacy, Pusan National University, from 2007 to 2011. He has made contributions to the field, serving as an associate editor and editor (2011-2022) of the Archives of Pharmacal Research (APR). Now he serves as an associate editor for the Journal of Controlled Release (JCR) since 2024. He has also been an editorial board member for JCR (2021~) and the Asian Journal of Pharmaceutical Sciences (2012~). He has held the positions of ‘Chief’ of the Academic Program Committee for the International Conferences and ‘Secretary General’ in the Korean Society of Pharmaceutical Sciences and Technology (KSPST) and the Controlled Release Society (CRS) Korea Chapter (2022-2023). Moreover, he served as a member of Annual Meeting Program Committee (AMPC) of 2026 CRS Lisbon. For over 20 years, his research has focused on various topics such as cancer-targeted therapy using multifunctional nanoparticles, photoreactive inorganic nano/biomaterials, and inhalation delivery systems for treating lung diseases. Throughout his career, Prof. Youn has authored over 238 SCI papers since 2001.

Representative Publications

[1]    Le XT , Youn YS*.  Single-atom catalysts: Enzyme-mimicking coordinations, platform designs, and biomedical applications. Coord. Chem. Rev. 2025;536:216642.

[2]    Le XT, Nguyen NT, Lee WT, Yang Y, Choi HG, Youn YS*. Peroxidase-Mimicking Iron‐Based Single‐Atom Upconversion Photocatalyst for Enhancing Chemodynamic Therapy. Adv. Funct. Mater. 2024;34(34):2401893.

[3]    Lee WT, Lee H, Kim J, Jung Y, Choi E, Jeong JH, Jeong J-H, Lee JH, Youn YS*. Alveolar macrophage phagocytosis-evading inhaled microgels incorporating nintedanib-PLGA nanoparticles and pirfenidone-liposomes for improved treatment of pulmonary fibrosis. Bioact. Mater. 2024;33:262-278.

[4]   Kim H, Yoon J, Kim HK, Lee WT, Nguyen NT, Le XT, Lee EH, Lee ES, Oh KT, Choi HG, Youn YS*. Upconverting nanoparticle-containing erythrocyte-sized hemoglobin microgels that generate heat, oxygen and reactive oxygen species for suppressing hypoxic tumors. Bioact. Mater. 2023;22:112-126.

[5]   Nguyen NT, Kim J, Le XT, Lee WT, Lee ES, Oh KT, Choi HG, Youn YS*. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy. ACS Nano. 2023;17(1):382-401.